For the year ending 2025-12-31, INVA has $1,635,165K in assets. $550,941K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 550,941 | |||
| Accounts receivable | 34,966 | |||
| Receivable from collaboration arrangements | 58,351 | |||
| Inventory | 39,172 | |||
| Prepaid expenses | 26,721 | |||
| Current portion of isp fund investments | 15,727 | |||
| Other current assets | 1,637 | |||
| Total current assets | 727,515 | |||
| Property and equipment, net | 1,555 | |||
| Equity method investments | 193,726 | |||
| Equity and long-term investments | 404,497 | |||
| Gross carrying value | 220,000 | |||
| Accumulated amortization | 163,862 | |||
| Capitalized fees paid, net | 56,138 | |||
| Right-of-use assets | 10,929 | |||
| Goodwill | 17,905 | |||
| Intangible assets | 182,156 | |||
| Deferred tax assets, net | 0 | |||
| Other assets | 40,744 | |||
| Total assets | 1,635,165 | |||
| Accounts payable | 4,966 | |||
| Accrued personnel-related expenses | 9,100 | |||
| Accrued interest payable | 1,618 | |||
| Deferred revenue | 4,270 | |||
| Income tax payable | 274 | |||
| Convertible notes, due 2025, net of issuance costs | 0 | |||
| Other accrued liabilities | 29,468 | |||
| Total current liabilities | 49,696 | |||
| Long-term debt, net of discount and issuance costs | 257,731 | |||
| Other long-term liabilities | 66,091 | |||
| Deferred tax liabilities, net | 31,793 | |||
| Income tax payable, long-term | 57,013 | |||
| Common stock 0.01 par value, 200,000 shares authorized, 74,636 and 62,665 issued and outstanding as of december 31, 2025 and 2024 respectively | 747 | |||
| Additional paid-in capital | 902,726 | |||
| Retained earnings (accumulated deficit) | 269,368 | |||
| Total stockholders' equity | 1,172,841 | |||
| Total liabilities and stockholders' equity | 1,635,165 | |||
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)